Related Experiment Videos

Differences in reactivity to cyclosporin A and interferon-gamma of normal and HPV-transformed keratinocytes

A V Marionnet1, G Lizard, M C Chignol

  • 1INSERM U346 Pavillon, R, Hôpital E. Herriot, Lyon, France.

Anticancer Research
|January 1, 1996
PubMed

Insights

Cyclosporin A (CsA) and Interferon-gamma (IFN-gamma) inhibit epithelial cell growth and alter cell cycles, particularly in human papillomavirus (HPV)-transformed cells. These drugs affect normal and HPV-transformed cells differently.

Area of Science:

  • Immunopharmacology
  • Dermatology
  • Oncology

Background:

  • Cyclosporin A (CsA) prevents organ transplant rejection but can lead to skin cancers, some linked to human papillomavirus (HPV).
  • Interferon-gamma (IFN-gamma) is a local treatment for persistent lesions in the general population.
  • The effects of CsA and IFN-gamma on keratinocytes are not fully understood.

Purpose of the Study:

  • To investigate the in vitro effects of CsA and IFN-gamma on normal and HPV-transformed epithelial cells.
  • To compare the cellular responses to these drugs in different cell types.

Main Methods:

  • Normal and HPV-transformed epithelial cell cultures were exposed to varying concentrations of CsA and IFN-gamma for 1-3 days.
  • Cell proliferation, morphology, and cell cycle distribution were analyzed.

Main Results:

  • No cytotoxicity was observed at the tested concentrations.
  • Both CsA and IFN-gamma inhibited cell growth and altered cell morphology.
  • CsA induced cytoplasmic vacuoles in some cells.
  • Cell cycle analysis revealed S-phase accumulation, especially in HPV-transformed cells, after treatment with higher doses of CsA or IFN-gamma.

Conclusions:

  • CsA and IFN-gamma differentially impact normal and HPV-transformed epithelial cells.
  • The drugs inhibit cell proliferation and affect cell cycle progression.
  • Further research is needed to clarify the specific mechanisms and implications for skin carcinogenesis.

Related Concept Videos